Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 12.5
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 25 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- There are no relevant experimental data on repeated exposure by inhalation. A conservative approach is used assuming a two times higher absorption via the inhalation route (end route) as compared to the oral route (start route).
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No additional assessment factor for duration extrapolation has to be applied as a chronic study is used as starting point.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route-to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole database is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- No additional factor for remaining uncertainties is required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.14 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 17.5
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- There are no relevant experimental data on repeated exposure by dermal route. Dermal absorption is anticipated to be 50 % of oral absorption. For details, please refer to the discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No additional factor is required as a chronic study was used as starting point.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The recommended factor for allometric scaling from dog to human is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- No additional factor is required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.42 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- DNEL extrapolated from long term DNEL
- Explanation for the modification of the dose descriptor starting point:
- see long-term systemic dermal DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.01 mg/cm²
- Most sensitive endpoint:
- skin irritation/corrosion
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3.2
- Dose descriptor:
- other: NOAEL
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No additional assessment factor for duration extrapolation has to be applied (local effects).
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Since the mechanism (direct chemical reactivity with cell membranes) of skin irritation/corrosion is considered to be the same in experimental animals and in human, no inter-species AF should be applied to the NOEC (in accordance with “Guidance on information requirements and chemical safety assessment, chapter R8: Characterisation of dose[concentration]-response for human health”, November 2012).
- AF for other interspecies differences:
- 1
- Justification:
- No additional AF for interspecies differences is required.
- AF for intraspecies differences:
- 3.2
- Justification:
- The chemical reactivity is the principle concern in this case. Therefore, for the intraspecies AF only 3.2 (3.16 ~3.2) for the toxicodynamic variability (in accordance with “Guidance on information requirements and chemical safety assessment, chapter R8: Characterisation of dose[concentration]-response for human health”, November 2012) was applied.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- No additional factor is required.
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General
DNEL derivation is performed under consideration of the recommendations of ECHA. In view of the data used for evaluation, the "quality of whole database factors" and "dose-response factors" are considered to amount each to a value of 1, and are thus not shown in the calculations presented below.
Workers – Hazard via inhalation route
Long term systemic DNEL, worker, inhalation route
Calculation of dose descriptor
Step 1: Selection of the relevant dose descriptor (starting point):
For risk characterization an inhalation NOAEC was derived by route to route extrapolation.
The oral NOAEL of 10 mg/kg bw/day, obtained from a chronic repeated dose toxicity testing with a read across-substance in dogs was considered as key value for the chemical safety assessment and therefore most relevant starting point.
Step 2: Modification into a correct starting point:
In a first step the oral NOAEL was transferred to humans with a factor of 1.4 for allometric scaling from dogs. For worker a NOEC long-term, inhalation was calculated assuming 70 kg per person, 8h light activity (10 m³ breathing volume), and 50 % absorption via oral route and 100 % absorption via inhalatory route.
NOEC (Worker) inhalation = 10 mg/kg bw/day * 1/1.4 *70 kg * 1/10 m³ * 50 % Abs, (oral) / 100 % Abs, (inhal) = 25 mg/m³
Step 3: Use of assessment factors: 12.5
Interspecies: no allometric scaling factor is applied because a oral-to-inhalation route extrapolation is performed.
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
In conclusion the long term systemic inhalation DNEL workers was calculated to be 2 mg/m³ bw/day.
Short term acute inhalation DNEL, worker
Due to the low vapour pressure of the substance no peak exposure is to be expected and therefore no acute systemic worker-DNEL for the inhalatory route has to be derived (in accordance with "Guidance on information requirements and chemical safety assessment", Chapter R8, November 2012).
Local effects
No data on local toxicity after inhalation is available. The substance is classified into skin irritation/corrosion cat. 1B according to Regulation (EC) No 1272/2008 (CLP). Therefore local mucosal membrane damage cannot be excluded (in accordance with "Guidance on information requirements and chemical safety assessment, chapter R8"). The substance is therefore allocated to the high hazard band. A qualitative risk assessment is conducted (according to "Guidance on information requirements and chemical safety assessment part E: risk characterisation", Nov. 2012).
Workers – Hazard via dermal route
Long term systemic DNEL, worker, dermal route
Calculation of dose descriptor
Step 1: Selection of the relevant dose descriptor (starting point):
For risk characterization a dermal NOAEC was derived by route to route extrapolation.
The oral NOAEL of 10 mg/kg bw/day, obtained from a chronic repeated dose toxicity testing with a read across-substance in dogs was considered as key value for the chemical safety assessment and therefore most relevant starting point.
Step 2: Modification into a correct starting point:
An absorption rate of 50 % through skin was deduced, as dermal uptake of quaternary ammonium ions can be slowed due to their reactivity and binding to skin components (in accordance with “Guidance on information requirements and chemical safety assessment, Chapter R.7c: Endpoint specific guidance”). In conclusion, the dermal NOAEL = oral NOAEL x [ABS oral dog/ABS dermal human] = 10 mg/kg bw/day x (100/50)= 20 mg/kg bw/day
Step 3: Use of assessment factors: 17.5
Interspecies: allometric scaling (dog to human): 1.4
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
In conclusion the long term systemic inhalation DNEL workers was calculated to be 1.14 mg/kg bw/day.
Acute short term DNEL, worker, dermal route
The substance is classified for acute dermal toxicity into cat. 3 according to Regulation (EC) No 1272/2008 (CLP) and therefore the DNEL for acute toxicity was derived by multiplying the long-term DNEL with a default factor of 3 (according to "Guidance on information requirements and chemical safety assessment", chapter R8, November 2012).
Local effects
Long term local DNEL, worker, dermal route
Step 1: Selection of the relevant dose descriptor (starting point):
For risk characterization the local dermal NOAEC was derived from the NOAEL of the read across substance obtained in a 2 weeks skin irritation study in rats considering the different Molecular Weights (MW) of the target substance and of the source substance (362.1 g/mol). For this calculation, a molecular weight of 207.8 g/mol was used for the target substance. The following formula has been applied:
NOAEL(target substance) = (NOAEL(source substance)/ MW(source substance)) x MW(target substance)= (6mg/kg bw/day /362.1) x 207.8= 4.5 mg/kg bw/day
Step 2: Modification into a correct starting point:
It was assumed that the treated body surface was 10 %. The total surface body of rat (male and female) is 400 cm2 and the mean body weight is 300 g. Assuming that 10 % of the body surface has been exposed to the test substance, the resulting exposed area is of 40 cm2.
For the characterization of the risk due to the local dermal effects a NO(A)EC (expressed in mg/cm2) was derived according to the following formula:
NOAEC in mg /cm2 =( Total dose applied in mg)/( Treated surface in cm2) =
(average animal weight in kg * dose in mg kg bw)/ (treated surface area in cm2)
NOAEC = (0.3 kg x 4.5 mg/kg bw/day) / 40cm2 = 0.034 mg/cm2
Step 3: Use of assessment factors: 3.2
Interspecies: Since the mechanism (direct chemical reactivity with cell membranes) of skin irritation/corrosion is considered to be the same in experimental animals and in human, no inter-species AF should be applied to the NOEC (in accordance with “Guidance on information requirements and chemical safety assessment, chapter R8: Characterisation of dose[concentration]-response for human health”, November 2012).
Intraspecies AF (worker): Regarding intra-species differences it could be acceptable to lower the default factor, given that chemical reactivity is the principle concern. Therefore, for the intraspecies AF only 3.16 for the toxicodynamic variability (in accordance with “Guidance on information requirements and chemical safety assessment, chapter R8: Characterisation of dose[concentration]-response for human health”, November 2012) could be taken into consideration (3.16 ~3.2).
Therefore, for the dermal route the overall AF turns out to be 3.2
In conclusion the long term local dermal DNEL workers was calculated to be 0.01 mg/cm2 /day.
Short term local DNEL, worker, dermal route
The substance is classified as skin corrosive, cat. 1B according to Regulation (EC) No 1272/2008 (CLP) and therefore associated to the high Hazard Band. A qualitative risk assessment is conducted (according to "Guidance on Information Requirements and Chemical Safety Assessment Part E: Risk Characterisation", Nov. 2012).
Worker – Hazard for the eyes
The substance is classified for skin corrosion into cat. 1B and labelled with H314 (Causes severe skin burns and eye damage) according to Regulation (EC) No 1272/2008 (CLP) and therefore associated to the medium Hazard Band. A qualitative risk assessment is conducted (according to "Guidance on Information Requirements and Chemical Safety Assessment Part E: Risk Charactersisation", Nov. 2012).
References
(not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1. November 2012.
- ECHA (2010). Guidance on information requirements and chemical safety assessment. Chapter R.7.12: Endpoint specific guidance: Guidance on Toxicokinetics. November 2012.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
